Patent details
EP3445368 Title: COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS
Basic Information
- Publication number:
- EP3445368
- PCT Application Number:
- US2017028996
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP177867744
- PCT Publication Number:
- WO2017185061
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS
- French Title of Invention:
- COMPOSÉS ET PROCÉDÉS POUR TRAITER DES ÉTATS NEUROLOGIQUES ET CARDIOVASCULAIRES
- German Title of Invention:
- VERBINDUNGEN UND VERFAHREN ZUR BEHANDLUNG VON NEUROLOGISCHEN UND KARDIOVASKULÄREN ERKRANKUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 14/08/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 06/09/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 17/07/2024
- Unitary Effect Registration Date:
- 06/09/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 21/04/2017
- Grant date:
- 17/07/2024
- EP Publication Date:
- 27/02/2019
- PCT Publication Date:
- 26/10/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 17/07/2024
- EP B1 Publication Date:
- 17/07/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 21/04/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/07/2024
- Name:
- Astrocyte Pharmaceuticals, Inc.
- Address:
- 245 First Street Suite 1800, Cambridge, Massachusetts 02142, United States (US)
- Name:
- Board of Regents, The University of Texas System
- Address:
- 210 West 7th Street, Austin, TX 78701, United States (US)
- Name:
- The U.S.A. as represented by the Secretary, Department of Health and Human Services
- Address:
- National Institues of Health 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, United States (US)
Inventor
1
- Name:
- JACOBSON, Kenneth A.
- Address:
- United States (US)
2
- Name:
- LISTON, Theodore E.
- Address:
- United States (US)
3
- Name:
- KORINEK, William S.
- Address:
- United States (US)
4
- Name:
- LECHLEITER, James D.
- Address:
- United States (US)
Priority
- Priority Number:
- 201662325860 P
- Priority Date:
- 21/04/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/52; A61K 31/7076; A61K 31/519; A61P 25/00; A61P 9/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202429
- Publication date:
- 17/07/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202429
- Publication date:
- 17/07/2024
- Description:
- Grant (B1)
3
- Issue number:
- 202431
- Publication date:
- 31/07/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
4
- Issue number:
- 202438
- Publication date:
- 18/09/2024
- Description:
- Unitary Effect Request Receipt
5
- Issue number:
- 202441
- Publication date:
- 09/10/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|